Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 28.09.2026 2 Am J Kidney Dis 1 BMC Ophthalmol 2 BMJ 1 Br J Ophthalmol 3 Diabet Med 13 Diabetes 8 Diabetes Care 5 Diabetes Obes Metab 3 Diabetologia 1 Eur J Endocrinol 1 Invest Ophthalmol Vis Sci 2 J Clin Endocrinol Metab 4 J Diabetes Complications 1 J Hypertens 1 Obstet Gynecol 1 Pediatrics 1 PLoS Med 6 PLoS One 1 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. ORTEGA-MONTIEL J, Alkabbani W, Hahn G, Liu J, et al
   Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.
   Am J Kidney Dis. 2026 Sep 21:S0272-6386(26)01118.
   PubMed         Abstract available
   
   
2. MENG X, Wang Y, Zhang X, Wang S, et al
   Time in Target Range for Hemoglobin A(1c) and Systolic Blood Pressure: Association With Adverse Kidney Events.
   Am J Kidney Dis. 2026;88:521-530.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

3. ELMI SADR N, Ghiasian L, Hadi Y, Hariri R, et al
   The effect of cycloplegia on corneal power and diameter measured by an auto-kerato-refractometer in presbyopic patients with type 2 diabetes mellitus: a post-hoc analysis of a randomized clinical trial.
   BMC Ophthalmol. 2026;26:588.
   PubMed         Abstract available
   
   

   
   BMJ

4. TURCHIN A, Petito LC, Hegermiller E, Chelliah I, et al
   Renal outcomes in people with type 2 diabetes with and without albuminuria treated with SGLT-2 inhibitors and GLP-1 receptor agonists: target trial emulation.
   BMJ. 2026;394:e100574.
   PubMed         Abstract available
   
   
5. TANNE JH
   American Diabetes Association boycotted in free speech row.
   BMJ. 2026;394:e100925.
   PubMed        
   
   

   
   Br J Ophthalmol

6. SPARTALIS C, Ruiss M, Dechat T, Kronschlager M, et al
   Intracapsular metformin bioactivity and its role in posterior capsule opacification.
   Br J Ophthalmol. 2026;110:1157-1163.
   PubMed         Abstract available
   
   

   
   Diabet Med

7. 
   Psychosocial care and experiences in young adults living with early-onset type 2 diabetes: A narrative review.
   Diabet Med. 2026;43:e70472.
   PubMed        
   
   
8. WIT M, Forde R, Holmes-Truscott E
   From strength to strength: Why psychosocial research in diabetes is more important than ever.
   Diabet Med. 2026;43:e70458.
   PubMed        
   
   
9. CLEAL B, Skovlund S, Skinner TC, O'Donnell S, et al
   Where is the social in the psychosocial? A narrative review.
   Diabet Med. 2026;43:e70201.
   PubMed         Abstract available
   
   

   
   Diabetes

10. GUO Z, Kasinathan D, Yun S, Golson ML, et al
    Islet-Targeted ZnT8 Antibodies Protect Pancreatic beta-Cells From Inflammatory Stress.
    Diabetes. 2026;75:1892-1905.
    PubMed         Abstract available
    
    
11. BURKETT JB, Fuhr J, Falk AC, Dadi P, et al
    Dual Modulation of Prostaglandin E2 Receptors EP3 and EP4 Protects beta-Cell Mass in a Model of Aggressive Autoimmune Inflammation.
    Diabetes. 2026 Jul 31:db251007. doi: 10.2337/db25-1007.
    PubMed         Abstract available
    
    
12. CHEN F, Zhang Y, Wang W, Li G, et al
    Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes.
    Diabetes. 2026;75:1934-1945.
    PubMed         Abstract available
    
    
13. AMENDOLARA R, De Vita F, Buzzetti R, Maddaloni E, et al
    Response to Comment on Amendolara et al. Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
    Diabetes. 2026;75:e39.
    PubMed        
    
    
14. RAINERI D, Chiocchetti A
    Response to Comments on Raineri et al. Memory Regulatory T Cells as a Biomarker of Early Type 1 Diabetes.
    Diabetes. 2026;75:e31-e33.
    PubMed        
    
    
15. CHEN J, Zhao Q, Hua Y, Zhao Y, et al
    Comment on Meier et al. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.
    Diabetes. 2026;75:e34-e35.
    PubMed        
    
    
16. PETSIOU A, Vartholomatos G, Paschou SA, Chatzigianni K, et al
    Comment on Raineri et al. Memory Regulatory T Cells as a Biomarker of Early Type 1 Diabetes.
    Diabetes. 2026;75:e27-e28.
    PubMed        
    
    
17. PAGE B
    Diabetes Spotlight: Mark A. Herman, MD-The Metabolic Effects of Excess Nutrients.
    Diabetes. 2026;75:1711-1712.
    PubMed        
    
    
18. MEIER CZ, Birkenfeld AL, Fritsche A, Stefan N, et al
    Response to Comment on Meier et al. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study.
    Diabetes. 2026;75:e36.
    PubMed        
    
    
19. CHEN J, Feng Z, Chen S
    Comment on Lyu et al. Type 2 Diabetes Reduces IFN-alpha2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice.
    Diabetes. 2026;75:e40-e41.
    PubMed        
    
    
20. CHEN J, Lin Y, Yang Y
    Comment on Amendolara et al. Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
    Diabetes. 2026;75:e37-e38.
    PubMed        
    
    
21. BRUZZANITI S, Piemonte E, Galgani M
    Comment on Raineri et al. Memory Regulatory T Cells as a Biomarker of Early Type 1 Diabetes.
    Diabetes. 2026;75:e29-e30.
    PubMed        
    
    
22. GOOTJES C, Nikolic T, Roep BO
    Comment on Raineri et al. Memory Regulatory T Cells as a Biomarker of Early Type 1 Diabetes.
    Diabetes. 2026;75:e25-e26.
    PubMed        
    
    

    
    Diabetes Care

23. SATTAR N, Gerstein HC, D'Alessio D, Bhatt DL, et al
    Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.
    Diabetes Care. 2026;49:1771-1778.
    PubMed         Abstract available
    
    
24. FLEMING GA, Mathieu C, Skyler JS
    The Importance of C-Peptide for Developing T1D Disease-Modifying Therapies.
    Diabetes Care. 2026;49:1752-1756.
    PubMed         Abstract available
    
    
25. RAWSHANI A, Eliasson B, McGuire DK, Sattar N, et al
    Association of Age at Type 1 Diabetes Onset With Survival, Cardiovascular, and Kidney Outcomes: A Nationwide Cohort Study.
    Diabetes Care. 2026 Sep 21:dc260200. doi: 10.2337/dc26-0200.
    PubMed         Abstract available
    
    
26. CHEN L, Wang J
    Semaglutide Effects on Insulin Sensitivity and beta-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial W
    Diabetes Care. 2026 Sep 21:dc260540. doi: 10.2337/dc26-0540.
    PubMed        
    
    
27. TOKI R, Sakamoto M, Takebayashi T
    Response to Comments on Toki et al. Seasonal BMI Amplitude and Risk of Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).
    Diabetes Care. 2026;49:e176-e177.
    PubMed        
    
    
28. LIU T, Zhu X, Wu Z
    Comment on Toki et al. Seasonal BMI Amplitude and Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).
    Diabetes Care. 2026;49:e174-e175.
    PubMed        
    
    
29. SHANG Y, Jin J, He Q
    Comment on Toki et al. Seasonal BMI Amplitude and Risk of Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).
    Diabetes Care. 2026;49:e173.
    PubMed        
    
    
30. 
    Automated Insulin Delivery for Pregnancy With Type 1 Diabetes: A Call to Action.
    Diabetes Care. 2026 Sep 24:dci260045. doi: 10.2337/dci26-0045.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

31. TAO Y, Yu H, Ma Y, Yuan M, et al
    Multimodal Exploratory Analysis of Persistent Diabetic Macular Edema: Integrating Aqueous Humour Metabolomics, Clinical and OCT Features.
    Diabetes Obes Metab. 2026 Sep 20. doi: 10.1111/dom.71173.
    PubMed         Abstract available
    
    
32. CALDERON E, Bjerg L, Isaksen AA, Sandbaek A, et al
    Sex and Socioeconomic Differences in the Initiation of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort Study.
    Diabetes Obes Metab. 2026 Sep 20. doi: 10.1111/dom.71334.
    PubMed         Abstract available
    
    
33. BALDASSARRE MPA, Di Dalmazi G, Carrieri F, Centorame G, et al
    Oral Semaglutide in Routine Clinical Practice: 24-Month Real-World Effectiveness, Persistence and Safety in Adults With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Sep 21. doi: 10.1111/dom.71371.
    PubMed         Abstract available
    
    
34. 
    Correction to 'Analysis of Patient Characteristics and Safety of Insulin Glargine U300 Use in 21 359 Patients With Type-2 Diabetes and Chronic Kidney Disease: DPV Registry Study'.
    Diabetes Obes Metab. 2026 Sep 23. doi: 10.1111/dom.71370.
    PubMed        
    
    
35. GRIFFITHS B, Mehar S, Blangiardo M, Bottle A, et al
    Evaluating the Effectiveness of the Reducing Weight With Intensive Dietary Support (REWIND) Programme on Type 2 Diabetes Remission.
    Diabetes Obes Metab. 2026 Sep 23. doi: 10.1111/dom.71364.
    PubMed         Abstract available
    
    

    
    Diabetologia

36. CARLSSON S, Tuomi T, Lampousi AM
    Lifestyle and environmental risk factors for adult-onset autoimmune diabetes: current evidence and future directions.
    Diabetologia. 2026 Sep 25. doi: 10.1007/s00125-026-06878.
    PubMed         Abstract available
    
    
37. FU Q, Wang K, Shen M, Shen S, et al
    Shared non-HLA genetic architecture across diverse ancestries links insulin secretion and resistance to type 1 diabetes.
    Diabetologia. 2026 Sep 22. doi: 10.1007/s00125-026-06865.
    PubMed         Abstract available
    
    
38. EHRMANN D, Hermanns N, Schmitt A, Klinker LY, et al
    Temporal dynamics of daily diabetes-specific burdens using intensive longitudinal data: the central role of feelings of guilt within a multilevel network analysis.
    Diabetologia. 2026 Sep 21. doi: 10.1007/s00125-026-06869.
    PubMed         Abstract available
    
    

    
    Eur J Endocrinol

39. HENNEY AE, Davison AS, Alam U, Cuthbertson DJ, et al
    Increased risk of steatotic liver disease, major adverse liver outcomes, cardiovascular events, and mortality in pheochromocytoma: a model of chronically elevated sympathetic tone.
    Eur J Endocrinol. 2026;195:529-539.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

40. MIDENA E, Lupidi M, Frizziero L, Midena G, et al
    The Behavior of the External Limiting Membrane and Ellipsoid Zone in Diabetic Macular Edema: A Population AI-Assisted Optical Coherence Tomography Study.
    Invest Ophthalmol Vis Sci. 2026;67:40.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

41. TAKAHARA M, Soga Y, Iida O
    Diabetes duration and advanced diabetes-related complications in lower-extremity versus coronary revascularization.
    J Clin Endocrinol Metab. 2026 Sep 25:dgag387. doi: 10.1210.
    PubMed         Abstract available
    
    
42. SABAG A, Biswas RK, Koemel NA, Francois ME, et al
    The dose-response association between wearables-quantified incidental physical activity and type 2 diabetes: a prospective cohort study.
    J Clin Endocrinol Metab. 2026 Sep 24:dgag316. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

43. TANG W, Luo R, Luo Y, Yu S, et al
    Prediction models for sarcopenia risk in type 2 diabetes mellitus: A systematic review and meta-analysis.
    J Diabetes Complications. 2026;40:109416.
    PubMed         Abstract available
    
    
44. BLOMSTRAND H, Halling A, Agvall B
    Three-year incidence and predictors of mortality and microvascular and macrovascular complications after newly diagnosed type 2 diabetes: A population-based cohort study.
    J Diabetes Complications. 2026;40:109415.
    PubMed         Abstract available
    
    
45. NEHME M, Baseme IS, Messier V, Dawe P, et al
    Diabetes phenotyping, insulin management and complications in latent autoimmune diabetes in adults (LADA): patient-reported outcomes of the Canadian BETTER registry.
    J Diabetes Complications. 2026;40:109417.
    PubMed         Abstract available
    
    
46. PATOULIAS D, Muzurovic E, Rizzo M, Mantzoros CS, et al
    Switching from glucagon-like peptide-1 receptor agonists to tirzepatide in type 2 diabetes: does therapeutic sequencing matter for metabolic dysfunction-associated steatotic liver disease?
    J Diabetes Complications. 2026 Sep 18:109418.
    PubMed        
    
    

    
    J Hypertens

47. ANNESI L, Agnoletti D, Angilletta E, Baracchi A, et al
    Maternal macrovascular and microvascular adaptation in healthy pregnancy, gestational diabetes, and hypertensive disorders of pregnancy.
    J Hypertens. 2026 Sep 18. doi: 10.1097/HJH.0000000000004414.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

48. WERNER EF
    Milestones in Motion: Gestational Diabetes.
    Obstet Gynecol. 2026 Sep 22. doi: 10.1097/AOG.0000000000006433.
    PubMed        
    
    

    
    Pediatrics

49. MONZON AD, Hoover JC, Pierce JS, Wasserman R, et al
    Behavioral Interventions in Pediatric Type 1 Diabetes Management: An Updated Meta-Analysis.
    Pediatrics. 2026 Sep 24:e2025075333. doi: 10.1542/peds.2025-075333.
    PubMed         Abstract available
    
    

    
    PLoS Med

50. BERGMAN E, Nordstrom A, Nyberg L, Nordstrom P, et al
    Association of a multiple risk factor assessment and intervention program with risk of diabetes: A population-based matched cohort study.
    PLoS Med. 2026;23:e1005043.
    PubMed         Abstract available
    
    

    
    PLoS One

51. FENG R, Wang X, Li X, Zhao Z, et al
    Identification and mechanistic investigation of novel biomarkers for diabetic retinopathy through hypoxia- and cuproptosis-associated gene analysis.
    PLoS One. 2026;21:e0358182.
    PubMed         Abstract available
    
    
52. CUADRADO-CORRALES N, Merida DM, Lopez-de-Andres A, Zamorano-Leon JJ, et al
    Nationwide trends in dementia subtypes and in-hospital mortality among hospitalizations with type 2 diabetes in Spain, 2021-2024: A focus on sex disparities.
    PLoS One. 2026;21:e0358874.
    PubMed         Abstract available
    
    
53. KAZI MAI, Mufarrih SM, Sirohi A, Hasan F, et al
    Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study.
    PLoS One. 2026;21:e0358659.
    PubMed         Abstract available
    
    
54. GU Z, Xi T, Luo X
    Use of faricimab for refractory diabetic macular edema in real-world clinical practice: When anatomical success meets functional limits.
    PLoS One. 2026;21:e0358993.
    PubMed         Abstract available
    
    
55. YAN J, Song Y, Du Y, Li F, et al
    Performance of machine learning-based prediction models for hypoglycemia in Chinese patients with diabetes: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0358876.
    PubMed         Abstract available
    
    
56. CHEN X, Lei M, Tang J, Wang H, et al
    Efficacy, safety, and feasibility of youth-derived fecal microbiota transplantation among adults with type 1 diabetes mellitus: A protocol of Pilot Randomized Controlled Trial.
    PLoS One. 2026;21:e0343078.
    PubMed         Abstract available
    
    

    
    Retina

57. HUANG RS, Naidu SC, Mihalache A, Benour A, et al
    Loss to Follow-Up and Subway Proximity in Proliferative Diabetic Retinopathy and Diabetic Macular Edema: CLEAR Study Report 2.
    Retina. 2026 Sep 21. doi: 10.1097/IAE.0000000000005018.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum